EUVIMEDEUVIMED entdecken
Multizentrische Studie

Depth of Response From Fixed‐Duration Treatment Is Associated With Superior Survival in Waldenstrom Macroglobulinemia

Jonas Paludo iD, Jithma P Abeykoon, Nirosha D Perera, Shayna Sarosiek iD, Joshua Gustine, Andres Ramirez-Gamero, Marzia Varettoni iD, Alessandra Tedeschi, Chiara Cavalloni, Anna Maria Frustaci iD, Levi D Pederson iD, Saurabh S Zanwar iD und 9 weitere

American Journal of Hematology · 2025

DOI: 10.1002/ajh.27663 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift American Journal of Hematology, 2025. Verfasst von Jonas Paludo und 20 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA. Hauptthemen laut MEDLINE: Waldenstrom Macroglobulinemia, Antineoplastic Combined Chemotherapy Protocols. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 31 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

As the treatment paradigm for Waldenström macroglobulinemia (WM) continues to evolve, the debate surrounding the prioritization of depth of response versus disease control as therapeutic goals gains significant relevance. However, the impact of depth of response from fixed‐duration therapy on overall survival (OS) was unclear. This multicenter study evaluated the prognostic impact of depth of response using a landmark survival analysis. A total of 440 patients with WM treated with frontline fixed‐duration regimens were included. Attaining a major response (MaR) was associated with superior outcomes, including significantly longer OS. The estimated 5‐year PFS rates for patients with MaR at 6 months versus not were 50% versus 32%, respectively, p < 0.001, and the estimated 5‐year OS rates for patients with MaR at 6 months versus not were 89% versus 70%, respectively, p < 0.001. In a multivariable analysis, MaR at 6 months was independently associated with superior PFS (HR 0.66, p = 0.007) and OS (HR 0.28, p < 0.001). Similar results were seen when considering deeper responses (CR + VGPR vs. PR). Depth of response at 6 months is an important prognostic marker in WM and an independent predictor of PFS and OS. These results support its utilization as a suitable endpoint in clinical studies in WM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Waldenstrom MacroglobulinemiaAntineoplastic Combined Chemotherapy ProtocolsHumansMaleAgedFemaleMiddle AgedAged, 80 and overSurvival RatePrognosisAdultRetrospective StudiesTreatment OutcomeDisease-Free SurvivalSurvival Analysis

Stichwörter der Autor:innen

Waldenstrom Macroglobulinemiafixed‐durationlymphoplasmacytic lymphomaoutcomestreatment

Autor:innen und Institutionen

  • Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.
  • Department of Cancer Medicine, MD Anderson Cancer Center, University of Texas, Houston, Texas, USA.
  • Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.
  • Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Department of Internal Medicine, Roger Williams Medical Center, Providence, Rhode Island, USA.
  • Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.

ORCID-Profile: Jonas Paludo, Shayna Sarosiek, Marzia Varettoni, Anna Maria Frustaci, Levi D Pederson, Saurabh S Zanwar, Thomas M Habermann, Thomas E Witzig, Morie A Gertz, Steven P Treon, Jorge J Castillo, Stephen M Ansell

Zitieren

APA

Paludo, J., Abeykoon, J. P., Perera, N. D., Sarosiek, S., Gustine, J., Ramirez-Gamero, A., Varettoni, M., Tedeschi, A., Cavalloni, C., Frustaci, A. M., Pederson, L. D., Zanwar, S. S., Kapoor, P., Habermann, T. M., Witzig, T. E., Kyle, R. A., Gertz, M. A., Geyer, S. M., Treon, S. P., …, & Ansell, S. M. (2025). Depth of Response From Fixed‐Duration Treatment Is Associated With Superior Survival in Waldenstrom Macroglobulinemia. American Journal of Hematology. https://doi.org/10.1002/ajh.27663

Vancouver

Paludo J, Abeykoon JP, Perera ND, Sarosiek S, Gustine J, Ramirez-Gamero A, et al. Depth of Response From Fixed‐Duration Treatment Is Associated With Superior Survival in Waldenstrom Macroglobulinemia. American Journal of Hematology. 2025. doi:10.1002/ajh.27663

BibTeX
@article{Paludo2025,
  author = {Paludo, Jonas and Abeykoon, Jithma P and Perera, Nirosha D and Sarosiek, Shayna and Gustine, Joshua and Ramirez-Gamero, Andres and Varettoni, Marzia and Tedeschi, Alessandra and Cavalloni, Chiara and Frustaci, Anna Maria and Pederson, Levi D and Zanwar, Saurabh S and Kapoor, Prashant and Habermann, Thomas M and Witzig, Thomas E and Kyle, Robert A and Gertz, Morie A and Geyer, Susan M and Treon, Steven P and Castillo, Jorge J and Ansell, Stephen M},
  title = {Depth of Response From Fixed‐Duration Treatment Is Associated With Superior Survival in Waldenstrom Macroglobulinemia},
  journal = {American Journal of Hematology},
  year = {2025},
  doi = {10.1002/ajh.27663}
}
Kostenlos starten →